News

VedaBio announces non-exclusive license agreement with Mammoth Biosciences for use of select CRISPR-based technologies in diagnostic applications ...
Flashpoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision-engineered structural ...
The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...
Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...
Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...
The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.
Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...
Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.
A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through ...
(MENAFN- GlobeNewsWire - Nasdaq) The global CRISPR-based gene editing market size is projected to grow from USD 4.46 billion in 2025 to over USD 13.39 billion by 2034, expanding at a CAGR of 13%.
More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, revolutionizing the ability to edit genes ...
Hybrid seed production is vital for enhancing crop yield and quality, yet conventional methods in rapeseed are limited by inefficiency and high costs.